Today, Novartis AG completed the spin-off of the Sandoz generics and biosimilars business, and Sandoz Group AG debuted as independent publicly traded ...
On 19 March 2023, following discussions initiated jointly by the Swiss Federal Department of Finance, the Swiss Financial Market Supervisory Authority ...
On 31 May 2022, DSM and Firmenich announced a cross-border merger-of-equals which unites two iconic companies into a leading creation and innovation ...